Vascular Implications of a Naturally Occurring Asthma Exacerbation
Sponsor: University of Alberta
Terminated
Poor study recruitment
Other terminated trials from University of Alberta
This observational or N/A phase trial investigates Asthma and Cardiovascular Risk Factor and is currently terminated or withdrawn. University of Alberta leads this study, which shows 21 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
21 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Aug 2024 — Sep 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2024 — Jun 2024 [monthly]
Recruiting
▶ Show 16 earlier versions
-
Feb 2024 — May 2024 [monthly]
Recruiting
-
Dec 2023 — Feb 2024 [monthly]
Recruiting
-
Sep 2023 — Dec 2023 [monthly]
Recruiting
-
May 2023 — Sep 2023 [monthly]
Recruiting
-
Jan 2023 — May 2023 [monthly]
Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Recruiting
-
May 2022 — Sep 2022 [monthly]
Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
-
May 2021 — Nov 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Recruiting
-
May 2019 — Nov 2019 [monthly]
Recruiting
-
Nov 2018 — May 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alberta
For direct contact, visit the study record on ClinicalTrials.gov .